Autor: |
Basavaraj A; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Segal L; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Samuels J; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Feintuch J; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Feintuch J; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Alter K; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Moffson D; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Scott A; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Addrizzo-Harris D; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA., Liu M; Division of Biostatistics, Department of Population Health and Environmental Medicine, New York University School of Medicine, USA., Kamelhar D; Division of Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, USA. |
Abstrakt: |
Antibiotic therapy against non-tuberculous mycobacteria (NTM) is prolonged and can be associated with toxicity. We sought to evaluate whether chest physical therapy (PT) was associated with clinical improvement in patients with NTM not receiving anti-mycobacterial pharmacotherapy. A retrospective review of 77 subjects that were followed from June 2006 to September 2014 was performed. Baseline time point was defined as the first positive sputum culture for NTM; symptoms, pulmonary function, and radiology reports were studied. Subjects were followed for up to 24 months and results analyzed at specified time points. Half of the subjects received chest PT at baseline. Cough improved at 12 (p = 0.001) and 24 months (p = 0.003) in the overall cohort when compared with baseline, despite lack of NTM antibiotic treatment. Cough decreased at 6 (p = 0.01), 9 (p = 0.02), 12 (p = 0.02) and 24 months (p = 0.002) in subjects that received chest PT. Sputum production also improved at 24 months in the overall cohort (p = 0.01). There was an increase in the percent change of total lung capacity in subjects that received chest PT (p = 0.005). Select patients with NTM may have clinical improvement with chest PT, without being subjected to prolonged antibiotic therapy. Future studies are warranted to prospectively evaluate outcomes in the setting of non-pharmacologic treatment and aid with the decision of antibiotic initiation. |